Skip to main content
. Author manuscript; available in PMC: 2023 May 26.
Published in final edited form as: Cell. 2022 May 13;185(11):1860–1874.e12. doi: 10.1016/j.cell.2022.04.024

Figure 6. Antibody Binding to Phages Pre- and Post-Phage Treatment Demonstrates Late Development of Anti-phage Neutralizing Antibodies.

Figure 6.

(A) Half maximal titers of IgG antibodies in pre-phage serum collected at day -1 and indicated times post-phage initiation for phages BPsΔ33HTH_HRM10 and D29_HRMGD40. Titers for two to six replicates are displayed as white data points on top of a mean bar ± s.d.

(B) Serum collected 1 day prior to phage initiation and indicated times post-phage initiation were tested for phage neutralization of BPsΔ33HTH_HRM10, D29_HRMGD40, and a control phage Fionnbharth Δ45–47. Data are representative of duplicate or triplicate assays.